InflaRx N.V. - InvestSnips

Stocks

Industries Foreign IPOs Large-Cap Mid-Cap Small-Cap Micro Cap Stocks S&P 500

ETFs

Bond ETFs ETF Profiles Commodity ETFs International ETFs Leveraged ETFs Nasdaq ETFs S&P 500 ETFs Sector ETFs

Skip to content

HOME
Stocks
ETFs
Stock Profiles
Privacy Policy

HOME
Stocks
ETFs
Stock Profiles
Privacy Policy

Company Name: InflaRx N.V.

InflaRx N.V. is a clinical stage biopharmaceutical company. The company is engaged in the development of C5a inhibitors.

Ticker Symbol: IFRX (NASDAQ)

Company Website: http://www.inflarx.com

Headquarters: Jena, Germany

Publicly Traded Companies by Sector and Industry

Companies in the S&P 500 by Category

Consumer Discretionary Stocks in the S&P 500

Consumer Staples Stocks in the S&P 500

Oil & Gas Stocks in the S&P 500

Financial Sector Stocks in the S&P 500

Healthcare Stocks in the S&P 500

Industrial Sector Stocks in the S&P 500

Materials Sector Stocks in the S&P 500

Real Estate Stocks in the S&P 500

Technology Stocks in the S&P 500

Telecommuications Stocks in the S&P 500

List of Utilities Stocks in the S&P 500

Providing data-driven insights for smart investing in public markets, crypto, and ETFs.

Facebook Twitter Youtube Linkedin

Quick Links

Quick Links

News & Insights

Quick Links

Terms of Service

Informational only, not financial advice.

© 2026 InvestSnips. All rights reserved